Skip to content

Magnesium sulphate added to lidocaine to improve pain relief after episiotomy repair.

The use of magnesium sulphate as an adjunct to lidocaine to prolong the post-episiotomy repair analgesia: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202510539125497
Enrollment
100
Registered
2025-10-03
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

MgSO4 plus lidocaine

Sponsors

Halima Ahmad
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • women between ages 19 years minimum and 44 years maximum • Term pregnancy (= 37 weeks' gestation). • Need for mediolateral episiotomy during vaginal delivery. • Gave verbal informed consent for participation.

Exclusion criteria

Exclusion criteria: • Have a known allergy or hypersensitivity to lidocaine or magnesium sulphate. • Have pre-eclampsia, eclampsia, or other hypertensive disorders of pregnancy. • Have coagulopathy, perineal infection, or third- or fourth-degree perineal tears. • Are using opioid analgesics or magnesium-containing medications. • They are unable to understand the pain assessment scale due to blindness or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
•Duration of analgesia post-intervention in both groups as elicited by Pain scores in both groups at regular time intervals post intervention and repair. •Time (in minutes) to first request for analgesic, which is the time from post-intervention to first demand of analgesia or low pain score in both groups. •Frequency of analgesic request post-intervention in both groups.

Secondary

MeasureTime frame
• Maternal satisfaction with pain relief post-intervention, in both groups, post-repair. • Frequency of occurrence of side effects of magnesium sulphate. post intervention

Countries

Nigeria

Contacts

Public ContactOlubunmi Abidemi Tunde Olatunji

consultant

olubunmiolatunji@gmail.com08035863359

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026